Fulgent Genetics (NasdaqGM:FLGT) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsAndrew Cooper - Director and Equity ResearchBrandon Perthuis - Chief Commercial OfficerDavid Westenberg - Managing Director and Equity ResearchLauren Sloane - Head of Investor RelationsLu Li - Healthcare Equity Research and DirectorMing Hsieh - Chairman and CEOPaul Kim - CFOOperatorGreetings, welcome to Fulgent Genetics Fourth Quarter 2025 Conference Call and Webcast. At this time, all participants are i ...

TTEC (NasdaqGS:TTEC) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsBob Belknap - Group VP, Corporate FinanceJonathan Lee - Managing Director, Equity ResearchKenneth R. Wagers III - CFOKenneth Tuchman - Chairman and CEOVincent A. Colicchio - Managing DirectorConference Call ParticipantsGeorge Sutton - Senior Research AnalystMaggie Nolan - Research Analyst, Technology, Media, and CommunicationsOperatorWelcome to TTEC's fourth quarter and full year 2025 earnings conference call. I wou ...

Via Transportation (NYSE:VIA) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsAdam Hotchkiss - Vice President of Emerging Software Equity ResearchBrian Peterson - Managing Director, Application SoftwareClara Fain - CFODaniel Ramot - Co-founder and CEOGabby McCaig - Chief Corporate Communications Officer and Head of Investor RelationsJonathan Ho - PartnerNone - Company RepresentativeConference Call ParticipantsAlex Zukin - Managing Director and Senior AnalystBrad Zelnick - Managing Di ...

Via Transportation (NYSE:VIA) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsAdam Hotchkiss - Vice President of Emerging Software Equity ResearchBrian Peterson - Managing Director, Application SoftwareClara Fain - CFODaniel Ramot - Co-founder and CEOGabby McCaig - Chief Corporate Communications Officer and Head of Investor RelationsJonathan Ho - PartnerNone - Company RepresentativeConference Call ParticipantsAlex Zukin - Managing Director and Senior AnalystBrad Zelnick - Managing Di ...

Core Insights - Synopsys reported a significant increase in first-quarter fiscal 2026 revenues, reaching $2.41 billion, which is a 65.5% year-over-year growth, surpassing the Zacks Consensus Estimate by 0.8% [2][10] - The company's EDA revenues were $1.1 billion, making up 45.6% of total revenues, while the Ansys product group contributed 36.8% of revenues, indicating strong demand for multiphysics simulation and digital engineering solutions [1][10] Financial Performance - Adjusted earnings for Synopsys in the reported quarter were $3.77 per share, exceeding the Zacks Consensus Estimate by 5.6% [1] - For fiscal 2026, Synopsys anticipates revenues between $9.56 billion and $9.66 billion, including $2.9 billion from Ansys, with a year-over-year growth projection of 36.5% [6] - Non-GAAP EPS is expected to be between $14.38 and $14.46, reflecting an increase from the previous range, while non-GAAP expenses are projected to be between $5.69 billion and $5.75 billion [7] Growth Drivers - The results were primarily driven by AI-led semiconductor demand and the integration of Ansys, which has enhanced Synopsys' capabilities in semiconductor R&D and design [3][10] - Synopsys is embedding AI throughout its EDA stack, leading to significant productivity gains for customers, with reported improvements such as 50% faster knowledge assistance and 5x quicker formal testbench generation [4][10] Market Positioning - The combined Synopsys-Ansys portfolio is strategically positioned to leverage the industry shift from physical prototyping to digital twins, facilitating faster and more cost-effective product development across various sectors, including aerospace and automotive [5][10] - For the second quarter of fiscal 2026, Synopsys expects revenues between $2.225 billion and $2.275 billion, with a year-over-year growth estimate of 40.3% [8]

Group 1 - The Marketing Cloud, a Stagwell company, announced significant expansions to its Agent Cloud platform, which simplifies access to AI tools and marketing assistants [1] - Since its launch in October 2025, Agent Cloud has seen a 30% increase in monthly agent interactions, reaching over 25,000 interactions per month [1] - The platform now supports over 500 custom-built agents and has increased daily engagement time by 25% [1]

Financial Data and Key Metrics Changes - The company reported total revenue of $322.7 million for 2025, representing a 14% increase year-over-year from $283.5 million in 2024 [18] - Fourth quarter revenue was $83.3 million, a slight decrease from $84.1 million in the third quarter of 2025 [18] - Non-GAAP gross margin for Q4 was 41%, while GAAP gross margin was 39.1% [18] - The GAAP loss for Q4 was $23.4 million, an increase from a loss of $6.6 million in the prior quarter [21] Business Line Data and Key Metrics Changes - Precision diagnostics revenue for Q4 was $48.2 million, an 11% increase year-over-year but down 5% sequentially [12] - Anatomic pathology (AP) revenue for Q4 was $27 million, a 3% increase year-over-year and up 4% sequentially [12] - Biopharma services revenue was $8.1 million for Q4, a 32% increase year-over-year and 10% sequentially [13] - For the full year, precision diagnostics revenue was $190.5 million, a 14% increase over 2024, while AP revenue was $106.4 million, a 10% increase [13] Market Data and Key Metrics Changes - The company anticipates a significant decrease in revenue from its largest customer, which accounted for $70.8 million or 22% of total revenue in 2025, as they transition testing in-house [24] - The anticipated contribution from the acquisition of Bako and StrataDx is expected to be approximately $50 million-$55 million in 2026 [24] Company Strategy and Development Direction - The company is focused on scaling efficiently and driving innovation across its service offerings while managing expenses and integrating strategic acquisitions effectively [26] - Investments in AI and digital pathology are expected to enhance operational efficiency and improve service quality [16] - The company plans to submit a request to the FDA for its first clinical candidate, FID-007, in Q2 2026, with a phase 3 trial initiation planned for the first half of 2027 [9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to recover from the loss of its largest customer, citing strong market demand and ongoing investments in technology [41] - The first half of 2026 is expected to be impacted by the transition of the largest customer, but the company anticipates stabilization in the second half [24] - The company expects total revenues to be approximately $350 million for 2026, representing an 8.5% year-over-year growth [24] Other Important Information - The company announced its intention to acquire Bako Diagnostics and StrataDx for a total purchase price of $55.5 million, pending regulatory approvals [13] - The company received approval from New York State for its proprietary NIPT offering and whole genome sequencing test, opening new markets for commercialization [14] Q&A Session Summary Question: Impact of largest customer moving in-house - Management confirmed that the revenue loss from the largest customer is approximately 70% for 2026, with expectations of $11.8 million from this customer [32] Question: Growth strategies for precision diagnostics - Management highlighted several drivers for growth, including expanded carrier screening tests and whole genome sequencing, with strong momentum expected in 2026 [36] Question: Capital allocation strategy post-acquisition - Management indicated a focus on AI capabilities and potential synergies from the Bako acquisition, with plans to invest in both organic growth and strategic acquisitions [42]

Financial Data and Key Metrics Changes - In Q4 2025, revenue grew 30% year-over-year to $119 million, marking the eighth consecutive quarter of 30% or more year-over-year growth [9][28] - The annual run rate revenue for Q4 2025 was $476 million, also reflecting a 30% year-over-year increase [28] - Adjusted EBITDA margin improved to negative 6%, the narrowest loss in the company's history, compared to negative 10% in Q4 2024 [34] Business Line Data and Key Metrics Changes - The number of customers on the platform increased to 821, a 23% year-over-year growth, with organic customer growth at 9% [10][29] - The acquisition of Downtowner added 94 new customers, expanding the platform's reach [10][29] - Revenue per customer reached the highest level in Via's history, with a 31% year-over-year growth in customers generating over $1 million in annual run rate revenue [29] Market Data and Key Metrics Changes - Platform revenue in the U.S. increased by 39% year-over-year, indicating strong growth in the domestic market [28] - The serviceable addressable market is estimated at $82 billion, with Via capturing just over 1% of this market [21][22] Company Strategy and Development Direction - The company aims to leverage its public company status for strategic acquisitions, with a focus on targeted and selective opportunities like Downtowner [14][16] - Product innovation is a key growth driver, with over 50 new products and major features released in 2025, significantly aided by AI [16][17] - The company is committed to achieving a long-term adjusted EBITDA margin of 20%-25% [36] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to continue delivering strong performance, emphasizing the significant opportunity in transforming public transit and local government efficiency [37] - The company expects revenue for Q1 2026 to be between $123.3 million and $123.8 million, representing 25%-25.5% year-over-year growth [35] - For the full year 2026, revenue guidance is set between $542.9 million and $545.1 million, with an expected adjusted EBITDA margin improvement [35] Other Important Information - The company achieved a record gross revenue retention rate of 98%, attributed to the mission-critical nature of its platform and the ability to sell more products to existing customers [11][29] - The company is focused on building AI-powered solutions that extend beyond public transit, responding to customer needs in various municipal operations [26][100] Q&A Session Summary Question: How much services come into Via's business model? - Management clarified that the services-only contracts are anomalies and emphasized the focus on software-enabled solutions as critical to scaling the business [41][42] Question: What does the RFP pipeline look like for 2026? - Management noted a consistent year-over-year RFP pipeline with a larger percentage of opportunities available compared to the previous year, driven by the expansion of solutions [48][50] Question: How does the company view gross retention and its impact on 2026 guidance? - Management indicated that high gross revenue retention is due to the platform's mission-criticality and the ability to sell more products, which strengthens customer relationships [105]

Market Overview - Global wearable device shipments surpassed 200 million units in 2025, marking a 6% year-on-year growth [1] - The market is experiencing increased consolidation among top vendors, with Xiaomi leading at 18% market share, followed by Apple at 17% and Huawei at 16% [1][5] Competitive Landscape - The competition in the wearables market is shifting from hardware-driven to ecosystem-led, emphasizing cross-device integration and monetizable data services [2] - Xiaomi's growth is attributed to a multi-category strategy, while Apple maintains a premium position through advanced health features and 5G connectivity [2] - Huawei is focusing on professional sports and medical-grade health applications to strengthen its market presence [2] Revenue Models - AI and subscription services are becoming essential revenue drivers, transforming from optional features to critical components for growth and profitability [3] - Subscription services are increasingly vital for vendors with higher-priced portfolios, providing a buffer against hardware margin compression due to rising component costs [3] Future Outlook - The global wearables market is expected to see modest single-digit growth in 2026, driven by advancements in on-device AI and demand for professional-grade health management [4] - Key physiological metrics, such as blood glucose and blood pressure monitoring, will be crucial for growth among leading smartwatch vendors [4] - Smartwatches are projected to show the strongest momentum, integrating advanced sensing and AI analytics for enhanced ecosystem connectivity [4]

Core Viewpoint - Block, the fintech company founded by Jack Dorsey, announced a significant layoff of approximately 40% of its workforce, equating to over 4,000 employees, which may be the largest single-round percentage job cut in S&P 500 history [1] Group 1: Company Strategy and Rationale - Dorsey framed the layoffs as a pivot towards AI, stating that the decision was not due to financial troubles but rather a response to a fundamental shift in the business landscape [2][3] - The company aims to adopt smaller and flatter teams enabled by intelligence tools, which Dorsey believes will fundamentally change company operations [3] Group 2: Employee Transition and Support - Departing employees will receive a severance package that includes 20 weeks of salary plus one week for each year of tenure, equity vested through the end of May, six months of healthcare, corporate devices, and $5,000 for transition support [4] Group 3: Market Reaction and Criticism - Following the announcement, Block's shares rose by 20% in after-hours trading, similar to trends seen in other tech companies that have announced layoffs with AI-focused justifications [5] - Critics argue that the AI rationale is questionable, especially given the company's recent history of increased spending, including a $68 million party for employees just five months prior to the layoffs [6][7] - Concerns have been raised about corporate bloat, as Block tripled its headcount from 2019 to 2022, and Dorsey has acknowledged overbuilding within the organization [7][8]